sun pharma semaglutide receives DCGI approval for Noveltreat, positioning itself strongly in India's fast-growing GLP-1 weight-management and diabetes therapy market ahead of patent expiry in 2026. #SunPharma #PharmaceuticalIndustry #GLP1 #Semaglutide Why Sun Pharma's semaglutide approval

Contact Enhanced Aesthetics & Wellness Today to schedule your consultation and discover how Semaglutide can make a difference in your life

Common GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) works on both GLP-1 and another hormone called GIP Most of these are shots you give yourself once a week

Increases in calcitonin levels have been observed in some patients, though the clinical significance remains uncertain

Strijbis K, Vaz FM, Distel B

Facial myokymia as the presenting feature of multiple sclerosis

Semaglutide will not chemically enlarge a stone you already have